119 related articles for article (PubMed ID: 33410342)
1. KLF4 inhibition by Kenpaullone induces cytotoxicity and chemo sensitization in B-NHL cell lines via YY1 independent.
Montecillo-Aguado M; Morales-Martínez M; Huerta-Yepez S; Vega MI
Leuk Lymphoma; 2021 Jun; 62(6):1422-1431. PubMed ID: 33410342
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Krüppel-Like Factor 4 (KLF4) expression through the transcription factor Yin-Yang 1 (YY1) in non-Hodgkin B-cell lymphoma.
Morales-Martinez M; Valencia-Hipolito A; Vega GG; Neri N; Nambo MJ; Alvarado I; Cuadra I; Duran-Padilla MA; Martinez-Maza O; Huerta-Yepez S; Vega MI
Oncotarget; 2019 Mar; 10(22):2173-2188. PubMed ID: 31040909
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-7 Regulates Migration and Chemoresistance in Non-Hodgkin Lymphoma Cells Through Regulation of KLF4 and YY1.
Morales-Martinez M; Vega GG; Neri N; Nambo MJ; Alvarado I; Cuadra I; Duran-Padilla MA; Huerta-Yepez S; Vega MI
Front Oncol; 2020; 10():588893. PubMed ID: 33194748
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of the KLF4 transcription factor inhibits the proliferation and migration of canine mammary tumor cells.
Tien YT; Chang MH; Chu PY; Lin CS; Liu CH; Liao AT
Vet J; 2015 Aug; 205(2):244-53. PubMed ID: 25616642
[TBL] [Abstract][Full Text] [Related]
5. KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma.
Guan H; Xie L; Leithäuser F; Flossbach L; Möller P; Wirth T; Ushmorov A
Blood; 2010 Sep; 116(9):1469-78. PubMed ID: 20519630
[TBL] [Abstract][Full Text] [Related]
6. Galiximab signals B-NHL cells and inhibits the activities of NF-κB-induced YY1- and snail-resistant factors: mechanism of sensitization to apoptosis by chemoimmunotherapeutic drugs.
Martinez-Paniagua MA; Vega MI; Huerta-Yepez S; Baritaki S; Vega GG; Hariharan K; Bonavida B
Mol Cancer Ther; 2012 Mar; 11(3):572-81. PubMed ID: 22267549
[TBL] [Abstract][Full Text] [Related]
7. Krüppel-like factor 4 contributes to the pathogenesis of mantle cell lymphoma.
Li XY; Geng LY; Zhou XX; Wei N; Fang XS; Li Y; Wang X
Leuk Lymphoma; 2017 Oct; 58(10):2460-2469. PubMed ID: 28278702
[TBL] [Abstract][Full Text] [Related]
8. Rituximab-induced inhibition of YY1 and Bcl-xL expression in Ramos non-Hodgkin's lymphoma cell line via inhibition of NF-kappa B activity: role of YY1 and Bcl-xL in Fas resistance and chemoresistance, respectively.
Vega MI; Jazirehi AR; Huerta-Yepez S; Bonavida B
J Immunol; 2005 Aug; 175(4):2174-83. PubMed ID: 16081784
[TBL] [Abstract][Full Text] [Related]
9. KLF4 promotes hydrogen-peroxide-induced apoptosis of chronic myeloid leukemia cells involving the bcl-2/bax pathway.
Li Z; Zhao J; Li Q; Yang W; Song Q; Li W; Liu J
Cell Stress Chaperones; 2010 Nov; 15(6):905-12. PubMed ID: 20401760
[TBL] [Abstract][Full Text] [Related]
10. Rituximab (chimeric anti-CD20) sensitizes B-NHL cell lines to Fas-induced apoptosis.
Vega MI; Huerta-Yepez S; Jazirehi AR; Garban H; Bonavida B
Oncogene; 2005 Dec; 24(55):8114-27. PubMed ID: 16103877
[TBL] [Abstract][Full Text] [Related]
11. Expression of KLF4 is a predictive marker for survival in pediatric Burkitt lymphoma.
Valencia-Hipόlito A; Hernández-Atenógenes M; Vega GG; Maldonado-Valenzuela A; Ramon G; Mayani H; Peña Alonso Y; Martinez-Maza O; Méndez-Tenorio A; Huerta-Yepez S; Bonavida B; Vega MI
Leuk Lymphoma; 2014 Aug; 55(8):1806-14. PubMed ID: 24067139
[TBL] [Abstract][Full Text] [Related]
12. A potential mechanism of rituximab-induced inhibition of tumor growth through its sensitization to tumor necrosis factor-related apoptosis-inducing ligand-expressing host cytotoxic cells.
Vega MI; Baritaki S; Huerta-Yepez S; Martinez-Paniagua MA; Bonavida B
Leuk Lymphoma; 2011 Jan; 52(1):108-21. PubMed ID: 21133714
[TBL] [Abstract][Full Text] [Related]
13. Role of the Transcription Factor Yin Yang 1 and Its Selectively Identified Target Survivin in High-Grade B-Cells Non-Hodgkin Lymphomas: Potential Diagnostic and Therapeutic Targets.
Vivarelli S; Falzone L; Ligresti G; Candido S; Garozzo A; Magro GG; Bonavida B; Libra M
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899428
[TBL] [Abstract][Full Text] [Related]
14. Kruppel-Like Factor 4 Positively Regulates Autoimmune Arthritis in Mouse Models and Rheumatoid Arthritis in Patients
Choi S; Lee K; Jung H; Park N; Kang J; Nam KH; Kim EK; Ju JH; Kang KY
Front Immunol; 2018; 9():1339. PubMed ID: 29997611
[TBL] [Abstract][Full Text] [Related]
15. Trichostatin A-induced apoptosis is mediated by Kruppel-like factor 4 in ovarian and lung cancer.
Zohre S; Kazem NK; Abolfazl A; Mohammad RY; Aliakbar M; Effat A; Zahra D; Hassan D; Nosratollah Z
Asian Pac J Cancer Prev; 2014; 15(16):6581-6. PubMed ID: 25169491
[TBL] [Abstract][Full Text] [Related]
16. Krüppel-like factor 4 (KLF4) induces mitochondrial fusion and increases spare respiratory capacity of human glioblastoma cells.
Wang S; Shi X; Wei S; Ma D; Oyinlade O; Lv SQ; Ying M; Zhang YA; Claypool SM; Watkins P; Xia S
J Biol Chem; 2018 Apr; 293(17):6544-6555. PubMed ID: 29507094
[TBL] [Abstract][Full Text] [Related]
17. Notch-1 regulates proliferation and differentiation of human bladder cancer cell lines by inhibiting expression of Krüppel-like factor 4.
Ai X; Jia Z; Liu S; Wang J; Zhang X
Oncol Rep; 2014 Oct; 32(4):1459-64. PubMed ID: 25109409
[TBL] [Abstract][Full Text] [Related]
18. KLF4 suppresses transformation of pre-B cells by ABL oncogenes.
Kharas MG; Yusuf I; Scarfone VM; Yang VW; Segre JA; Huettner CS; Fruman DA
Blood; 2007 Jan; 109(2):747-55. PubMed ID: 16954505
[TBL] [Abstract][Full Text] [Related]
19. KLF4 overexpression and apigenin treatment down regulated anti-apoptotic Bcl-2 proteins and matrix metalloproteinases to control growth of human malignant neuroblastoma SK-N-DZ and IMR-32 cells.
Mohan N; Ai W; Chakrabarti M; Banik NL; Ray SK
Mol Oncol; 2013 Jun; 7(3):464-74. PubMed ID: 23317647
[TBL] [Abstract][Full Text] [Related]
20. Deregulated KLF4 Expression in Myeloid Leukemias Alters Cell Proliferation and Differentiation through MicroRNA and Gene Targets.
Morris VA; Cummings CL; Korb B; Boaglio S; Oehler VG
Mol Cell Biol; 2016 Feb; 36(4):559-73. PubMed ID: 26644403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
